Dachaigh › Aillse (gach seòrsa) › Alabama
Sgrùdaidhean clionaigeach Aillse (gach seòrsa) ann an Alabama
Tha 37 sgrùdaidhean airson Aillse (gach seòrsa) a’ lorg phàirtichean aig làraichean ann an Alabama.
Bailtean ann an Alabama
Teacsa sgrùdaidh oifigeil (Beurla)
Feasibility of a Real-world, Financial Psycho-oncology Intervention to Address Cancer-related Financial Distress
- University of Alabama at Birmingham, Birmingham
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07724041A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- The Kirklin Clinic of UAB Hospital, Birmingham
- The University of Alabama at Birmingham, Birmingham
A’ fastadhÌre 2/3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06989437A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- UAB Medicine - UAB Hospital, Birmingham
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06901531Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 16, Birmingham
A’ fastadhÌre 3
Aoisean 18 gu 71 · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT07504458A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Birmingham Hematology and Oncology Associates d/b/a Alabama Oncology /ID# 280063, Birmingham
- Usa Mitchell Cancer Institute /ID# 280198, Mobile
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT07365241TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham
A’ fastadhÌre 2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT02693535Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- University of Alabama Birmingham, Birmingham
A’ fastadhÌre 2/3
Gach aois · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT03435796RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- UAB, Psychiatry and Behavioral Neurology, Birmingham
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT07002034A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
- The University of Alabama at Birmingham ( Site 1005), Birmingham
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT06818643A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Clearview Cancer Institute, Huntsville
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT06119581HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- University of Alabama at Birmingham Cancer Center, Birmingham
A’ fastadhÌre 1
36 Months – 22 Years · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT03911388Project: Every Child for Younger Patients With Cancer
- Children's Hospital of Alabama, Birmingham
- USA Health Strada Patient Care Center, Mobile
A’ fastadhSgrùdadh amharc
Suas gu aois 25 · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT02402244A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- Childrens Hospital of Alabama, Birmingham
A’ fastadhÌre 2
Aoisean 1 gu 39 · Gach gnè · Air ùrachadh 7 Lùna 2026 · NCT05999994Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- University of Alabama at Birmingham Cancer Center, Birmingham
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Lùna 2026 · NCT06580314Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- 004, Birmingham
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 16 Iuch 2026 · NCT06906341A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Clearview Cancer Institute - Huntsville - Cci Drive /ID# 278621, Huntsville
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Iuch 2026 · NCT07023289A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
- University of Alabama at Birmingham, Birmingham
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Iuch 2026 · NCT06997029A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
- University of Alabama at Birmingham, Division of Hematology and Oncology, Birmingham
A’ fastadh
Aoisean 60 agus nas sine · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT06697600A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
- GSK Investigational Site, Birmingham
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Ògmh 2026 · NCT06431594Childhood Cancer Survivor Study
- University of Alabama at Birmingham/Children's of Alabama, Birmingham
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Gach aois · Gach gnè · Air ùrachadh 17 Ògmh 2026 · NCT01120353Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- Birmingham VA Medical Center, Birmingham, AL, Birmingham
A’ fastadh
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 17 Ògmh 2026 · NCT05486572Multisite Implementation of COMPRENDO
- Children's of Alabama/University of Alabama at Birmingham, Birmingham
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Ògmh 2026 · NCT06055296Leading Healthy Eating and Activity Promotion Program
- University of Alabama at Birmingham, Birmingham
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 18 gu 89 · Gach gnè · Air ùrachadh 19 Cèit 2026 · NCT06868524Video Inspired Discussions About Ethical Outcomes in Pediatrics
- Children's of Alabama at Birmingham, Birmingham
A’ fastadh
Gach aois · Gach gnè · Air ùrachadh 14 Cèit 2026 · NCT06786104I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- University of Alabama at Birmingham, Birmingham
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Cèit 2026 · NCT01042379Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- University of Alabama at Birmingham, Birmingham
- University of South Alabama, Mobile
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Gibl 2026 · NCT05297734Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation
- University of Alabama at Birmingham, Birmingham
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Gearr 2026 · NCT07281287TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
- Alabama Oncology, Birmingham
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 99 · Gach gnè · Air ùrachadh 24 Gearr 2026 · NCT06207032Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
- The Kirklin Clinic, Birmingham
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Gearr 2026 · NCT07197515GEMINI-NSCLC: NSCLC Biomarker Study
- Alabama Oncology, Birmingham
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Gearr 2026 · NCT05236114Caris Biorepository Research Protocol
- University of South Alabama, Mobile
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Faoi 2026 · NCT01499394SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Birmingham
- Massive Bio SYNERGY-AI site, Mobile
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
- XCancer Research Network/Dothan Hematology & Oncology, Dothan
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Dàmh 2025 · NCT06228326BMT-CARE: Psychosocial Intervention for Transplant Caregivers
- University of Alabama at Brimingham, Birmingham
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Dàmh 2025 · NCT06472089Making Healthy Habits Stick
- University of Alabama at Birmingham, Birmingham
A’ fastadh
Aoisean 19 agus nas sine · Banairean · Air ùrachadh 1 Dàmh 2025 · NCT06745180Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- University of South Alabama Mitchell Cancer Institute, Mobile
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 27 Samh 2024 · NCT03860883Collection and Distribution of Biospecimens for Novel Research Uses
- iSpecimen, Huntsville
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
1 Month – 89 Years · Gach gnè · Air ùrachadh 9 Samh 2022 · NCT03848962Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.